Chartis: SAS an AML transaction monitoring leader

Walsh University Celebrates 100% Pass Rate for Psychiatric Mental Health Nurse Practitioner Grads

CECO Environmental Announces Upcoming Investor Conferences

McEwen Exercises Inventus Warrants and Increases Ownership to 12.7%

UBCC Launches HRM Platform to Help Independent Payroll Processors Compete and Grow

The S&P 500 Fell 2% or More on 85 Days From 2017 to 2025 and Still More Than Tripled

The S&P 500 Fell 2% or More on 85 Days From 2017 to 2025 and Still More Than Tripled

New Analysis Finds Lower Utility Returns Risk Higher Long-Term Costs for Customers

CTS Corporation Declares a Dividend

CPSC Posts New Product Recalls and Product Safety Warnings to its Web Site

Astō Consumer Partners Named to Inc.'s 2026 Founder-Friendly Investors list

Tech, Toys and Personalized Picks: Staples Canada Has Gifts for Everyone on the List

/C O R R E C T I O N - MPE Partners/

Disrupting AI Spending: Brian Kolbusz Targets the Pilot-to-Scale Gap

What 3.4% GDP Growth and a 4.2% Jobless Rate Say About a Hard Day on Wall Street

What 3.4% GDP Growth and a 4.2% Jobless Rate Say About a Hard Day on Wall Street

Quantix Strengthens Capital Structure and Appoints New Board of Directors

IQIRVO® late-breaking data raises ambitions in PBC with more than 85% of patients on treatment achieving ALP normalization

0zone Uses Continuous State Tracking to Pinpoint Pre-Advisory Exposure to PHP2Shell Flaws

Shield to acquire Echodyne in a transaction valued at $5.3 billion and raise $2.5 billion at a $28.8 billion valuation